Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Larsson

Showing results (41-50 of 316) with videos related to

Pageof 32
Sort By:
European Journal of Clinical Pharmacology|January 1, 1986
Effects of probenecid on enprofylline kinetics in manO Borgå, R Larsson, E Lunell
Acta Medica Scandinavica|January 1, 1979
The effect of cimetidine, a new histamine H2-receptor antagonist, on renal functionR Larsson, G Bodemar, B Kågedal
Biochemical Pharmacology|April 27, 2001
Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacologyS Ekelund, P Nygren, R Larsson
Acta Medica Scandinavica|January 1, 1988
Pharmacokinetics of chloral hydrate poisoning treated with hemodialysis and hemoperfusionT Buur, R Larsson, B Norlander
Annals of the New York Academy of Sciences|January 1, 1987
The search for thromboresistance using immobilized heparinR Larsson, O Larm, P Olsson
The Journal of Chemical Physics|October 16, 2021
Control of concerted back-to-back double ionization dynamics in heliumHenrik R Larsson, David J Tannor
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1983
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residueO Larm, R Larsson, P Olsson
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Quinton-Scribner arteriovenous shunts for hemodialysis. A review of 6.5 years' experienceM Lundberg, P Erlanson, R Larsson
Acta Radiologica: Diagnosis|November 1, 1976
Thromboresistance and stability of a heparinized polymerM Heideman, B Jacobsson, R Larsson
Anticancer Research|July 1, 1993
Difluoromethylornithine and ethylglyoxal bis(guanylhydrazone) as inhibitors of human renal carcinoma cell proliferation and polyamine metabolismA Sjöholm, R Larsson, P Nygren
Pageof 32

Showing results (41-50 of 316) with videos related to

Sort By:
Pageof 32
European Journal of Clinical Pharmacology|January 1, 1986
Effects of probenecid on enprofylline kinetics in manO Borgå, R Larsson, E Lunell
Acta Medica Scandinavica|January 1, 1979
The effect of cimetidine, a new histamine H2-receptor antagonist, on renal functionR Larsson, G Bodemar, B Kågedal
Biochemical Pharmacology|April 27, 2001
Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacologyS Ekelund, P Nygren, R Larsson
Acta Medica Scandinavica|January 1, 1988
Pharmacokinetics of chloral hydrate poisoning treated with hemodialysis and hemoperfusionT Buur, R Larsson, B Norlander
Annals of the New York Academy of Sciences|January 1, 1987
The search for thromboresistance using immobilized heparinR Larsson, O Larm, P Olsson
The Journal of Chemical Physics|October 16, 2021
Control of concerted back-to-back double ionization dynamics in heliumHenrik R Larsson, David J Tannor
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1983
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residueO Larm, R Larsson, P Olsson
Scandinavian Journal of Urology and Nephrology|January 1, 1977
Quinton-Scribner arteriovenous shunts for hemodialysis. A review of 6.5 years' experienceM Lundberg, P Erlanson, R Larsson
Acta Radiologica: Diagnosis|November 1, 1976
Thromboresistance and stability of a heparinized polymerM Heideman, B Jacobsson, R Larsson
Anticancer Research|July 1, 1993
Difluoromethylornithine and ethylglyoxal bis(guanylhydrazone) as inhibitors of human renal carcinoma cell proliferation and polyamine metabolismA Sjöholm, R Larsson, P Nygren
Pageof 32